Agenda – Medical Imaging in Clinical Research

  • Day 1
  • Day 2

Day 1

 Monday, February 12, 2018

9:00AM – 9:30AM

Chairperson’s Opening Remarks

Advanced Methods for Read Designs and Inter-Reader Variability

Colin Miller, Editor, MEDICAL IMAGING IN CLINICAL TRIALS

9:30AM – 10:15AM

Strategically Plan and Manage Imaging in Your Clinical Trial to Ensure Standardization Across Vendors
Neeta Fahey, Clinical Imaging Operations, Senior Clinical Protocol Manager, BRISTOL-MYERS SQUIBB

10:15AM – 10:45AM

Networking Break

10:45AM – 11:30AM

Implement PET Imaging As a Potential Go/ No-Go Decision in Early-Phase Clinical Trials
Jianqing Chen, PET and Molecular Imaging, PFIZER

11:30AM – 12:00PM

Novel PET Imaging Agents for Early Clinical Trials
Gary Ulaner, M.D., Ph.D., Associate Attending Radiologist, MEMORIAL SLOAN KETTERING CANCER CENTER

12:00PM – 1:00PM

Luncheon

1:00PM – 2:15PM

PANEL: Incorporate Experimental Imaging Agents in Drug Clinical Trials
MODERATOR:
Youngho Seo, Ph.D., Professor, Department of Radiology and Biomedical Imaging, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

PANELISTS:
Gary Ulaner, M.D., Ph.D., Associate Attending Radiologist, MEMORIAL SLOAN KETTERING CANCER CENTER
Dr. Christopher R. Hancock, Director of Neuroradiology, Blue Sky Radiology
Jianqing Chen, PET & Molecular Imaging, PFIZER

2:15PM – 3:00PM

Adopt Electronic Transfer of Imaging Data Across the Industry
Shawn Keen, Associate Director, Imaging Partner Relationship Lead, BRISTOL-MYERS SQUIBB

3:00PM – 3:30PM

Networking Break

3:30PM – 4:15PM

CASE STUDY: Fluorescent and Imaging Markers on Cells for the Demonstration of Lateral Epigenetic Shifting
Timothy Ganey, Chief Scientific Officer, Vivex Biomedical, Inc

4:15PM – 5:00PM

Operationalize Imaging Management in Clinical Trials
Sanjay Joshi, Chief of Technology, Healthcare and Life Sciences, IMAGING AND RADIOLOGY EXPERT – 25+ YEARS


Day 2

 Tuesday, February 13, 2018

8:00AM – 9:00AM

Continental Breakfast

9:30AM – 10:15AM

Artificial Intelligence in Medical Imaging: How to See the Unknown
Dr. Christopher R. Hancock, Director of Neuroradiology, Blue Sky Radiology

10:15AM – 11:00AM

Reader Challenges in Central Independent Reviews
Ira Smalberg, M.D., Diagnostic Radiology, TOWER IMAGING MEDICAL GROUP

11:00AM – 11:30AM

Networking Break

11:30AM – 12:15PM

Treatment of Neurological Disorders Using Molecular Imaging As a Guide
Dr. Johan Luthman, VP Neuroscience Clinical Development, EISAI

12:15PM – 1:15PM

Luncheon

1:15PM – 2:00PM

Utilize Imaging Modalities for Randomization and Endpoint Adjudication
Priya Guyadeen, Clinical Project Manager, Peripheral, PENUMBRA, INC.

2:45PM – 3:00PM

Chairperson’s Closing Remarks
Colin Miller, Editor, MEDICAL IMAGING IN CLINICAL TRIALS